Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk.

Li J, Flammer AJ, Reriani MK, Matsuo Y, Gulati R, Friedman PA, Thomas RJ, Sandhu NP, Lerman LO, Lerman A.

Circ J. 2013;77(3):780-5. Epub 2012 Dec 6.

2.

Is high leukocyte count synonymous with the presence of endothelial dysfunction or atherosclerosis?

Li J, Lerman A.

Circ J. 2014;78(4):1010. Epub 2014 Jan 28. No abstract available.

PMID:
24476803
3.

Is high leukocyte count synonymous with the presence of endothelial dysfunction or atherosclerosis?

Koza Y.

Circ J. 2014;78(4):1009. Epub 2014 Jan 28. No abstract available.

PMID:
24476802
4.

Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.

Soga J, Noma K, Hata T, Hidaka T, Fujii Y, Idei N, Fujimura N, Mikami S, Maruhashi T, Kihara Y, Chayama K, Kato H, Liao JK, Higashi Y; ROCK Study Group.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2353-9. doi: 10.1161/ATVBAHA.111.227892. Epub 2011 Jul 7.

5.

Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.

Li J, Flammer AJ, Lennon RJ, Nelson RE, Gulati R, Friedman PA, Thomas RJ, Sandhu NP, Hua Q, Lerman LO, Lerman A.

Mayo Clin Proc. 2012 Oct;87(10):968-75. doi: 10.1016/j.mayocp.2012.07.004. Epub 2012 Sep 12.

6.

Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.

Terlecki M, Bednarek A, Kawecka-Jaszcz K, Czarnecka D, Bryniarski L.

Kardiol Pol. 2013;71(3):260-7. doi: 10.5603/KP.2013.0038.

7.

Microvascular dysfunction and pulse wave reflection characterize different vascular pathologies in patients at cardiovascular risk.

Fischer-Rasokat U, Spyridopoulos I, Walter J, Honold J, Zeiher AM, Fichtlscherer S.

Vasa. 2012 May;41(3):192-9. doi: 10.1024/0301-1526/a000185.

PMID:
22565620
8.

Endothelial function and cardiovascular events in chronic kidney disease.

Hirata Y, Sugiyama S, Yamamoto E, Matsuzawa Y, Akiyama E, Kusaka H, Fujisue K, Kurokawa H, Matsubara J, Sugamura K, Maeda H, Iwashita S, Jinnouchi H, Matsui K, Ogawa H.

Int J Cardiol. 2014 May 15;173(3):481-6. doi: 10.1016/j.ijcard.2014.03.085. Epub 2014 Mar 20.

PMID:
24703800
9.

Screening of unrecognized peripheral arterial disease (PAD) using ankle-brachial index in high cardiovascular risk patients free from symptomatic PAD.

Mourad JJ, Cacoub P, Collet JP, Becker F, Pinel JF, Huet D, Sevestre-Pietri MA, Priollet P; ELLIPSE scientific committee and study investigators.

J Vasc Surg. 2009 Sep;50(3):572-80. doi: 10.1016/j.jvs.2009.04.055. Epub 2009 Jun 27.

10.

Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study.

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Hidaka T, Kihara Y, Chayama K, Noma K, Nakashima A, Goto C, Tomiyama H, Takase B, Yamashina A, Higashi Y.

Heart. 2013 Dec;99(24):1837-42. doi: 10.1136/heartjnl-2013-304739. Epub 2013 Oct 23.

11.

Prevalence of and risk factors for peripheral arterial disease in the patients with hypertension among Han Chinese.

Yang X, Sun K, Zhang W, Wu H, Zhang H, Hui R.

J Vasc Surg. 2007 Aug;46(2):296-302. Epub 2007 Jun 28.

12.

The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.

Grover SA, Lowensteyn I, Kaouache M, Marchand S, Coupal L, DeCarolis E, Zoccoli J, Defoy I.

Arch Intern Med. 2006 Jan 23;166(2):213-9.

PMID:
16432091
13.
14.

Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.

Al Mheid I, Patel R, Murrow J, Morris A, Rahman A, Fike L, Kavtaradze N, Uphoff I, Hooper C, Tangpricha V, Alexander RW, Brigham K, Quyyumi AA.

J Am Coll Cardiol. 2011 Jul 5;58(2):186-92. doi: 10.1016/j.jacc.2011.02.051.

15.

Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.

Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A.

Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

PMID:
21757955
16.

Prognostic significance of circulating leukocyte subtype counts in patients with coronary artery disease.

Yamamoto E, Sugiyama S, Hirata Y, Tokitsu T, Tabata N, Fujisue K, Sugamura K, Sakamoto K, Tsujita K, Matsumura T, Kaikita K, Hokimoto S.

Atherosclerosis. 2016 Dec;255:210-216. doi: 10.1016/j.atherosclerosis.2016.08.033. Epub 2016 Aug 25.

PMID:
27612676
17.

Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors: CArdiovascular PREvention Sacco Study (CAPRESS).

Perego F, Renesto E, Arquati M, Scandiani L, Cogliati C, Torzillo D, Zocchi L, Casazza G, Duca P, Chirchiglia S, Lacaita G, Panteghini M, Cortellaro M.

Intern Emerg Med. 2011 Aug;6(4):337-47. doi: 10.1007/s11739-010-0501-7. Epub 2010 Dec 17.

PMID:
21165713
18.

Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.

Shechter M, Issachar A, Marai I, Koren-Morag N, Freinark D, Shahar Y, Shechter A, Feinberg MS.

Int J Cardiol. 2009 May 1;134(1):52-8. doi: 10.1016/j.ijcard.2008.01.021. Epub 2008 May 13.

PMID:
18479768
19.

BMI vs. waist circumference for identifying vascular risk.

Freiberg MS, Pencina MJ, D'Agostino RB, Lanier K, Wilson PW, Vasan RS.

Obesity (Silver Spring). 2008 Feb;16(2):463-9. doi: 10.1038/oby.2007.75.

20.

Predictive value of the relative lymphocyte count in coronary heart disease.

Bian C, Wu Y, Shi Y, Xu G, Wang J, Xiang M, Weng S, Jiang J, Ma J.

Heart Vessels. 2010 Nov;25(6):469-73. doi: 10.1007/s00380-010-0010-7. Epub 2010 Oct 5.

PMID:
20922539

Supplemental Content

Support Center